Integrated systems approach identifies risk regulatory pathways and key regulators in coronary artery disease

Yan Zhang1, Dianming Liu1, Lihong Wang2

  • 1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.

Journal of Molecular Medicine (Berlin, Germany)
|July 26, 2015
PubMed
Abstract

Insights

We identified key regulatory pathways and upstream regulators involved in coronary artery disease (CAD) using an integrated systems approach. Phosphatase and tensin homolog (PTEN) is highlighted as a potential key regulator in CAD pathogenesis.

Area of Science:

  • Cardiovascular Research
  • Systems Biology
  • Genomics

Background:

  • Coronary artery disease (CAD) is a prevalent heart condition with poorly understood molecular mechanisms.
  • Regulatory pathways are critical in disease pathogenesis, making their identification crucial for understanding CAD.
  • Advances in high-throughput data necessitate novel computational approaches to dissect complex diseases.

Purpose of the Study:

  • To develop an integrated systems approach for identifying CAD risk regulatory pathways and key regulators.
  • To elucidate the molecular mechanisms and regulatory information flow in CAD initiation and progression.
  • To propose a novel method for prioritizing upstream regulators in disease pathways.

Main Methods:

  • A CAD-related core subnetwork was identified using a random walk algorithm on a curated transcription factor (TF) and microRNA (miRNA) regulatory network.
  • Candidate risk regulatory pathways were extracted via a breadth-first search (BFS) algorithm.
  • Pathway prioritization was performed using multiple CAD-associated data sources, and upstream regulators were ranked with a new measure.

Main Results:

  • An integrated systems approach successfully identified risk regulatory pathways in CAD.
  • A novel measure was proposed and applied to prioritize key upstream regulators.
  • The phosphatase and tensin homolog (PTEN) was identified as a potential key regulator in the dysregulation of identified risk pathways.

Conclusions:

  • The developed approach effectively identifies risk regulatory pathways and key regulators in CAD.
  • PTEN is implicated as a significant regulator in the context of CAD pathogenesis.
  • Understanding regulatory pathway dynamics offers insights into CAD etiology and progression.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
994
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
861
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
419
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
5.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
592